A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.

Clinical trial NCT04619433 · TERMINATED

Trial details

NCT number: NCT04619433
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-squamous Non-small-cell Lung Cancer

Start date: 2021-02-01
Primary completion: 2025-08-16
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.